Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

Rick Proschmann - , TUD Dresden University of Technology (Author)
Christoph Baldow - , Institute for Medical Informatics and Biometry, University Hospital Carl Gustav Carus Dresden (Author)
Tino Rothe - , TUD Dresden University of Technology (Author)
Meinolf Suttorp - , University Hospital Carl Gustav Carus Dresden (Author)
Christian Thiede - , Department of Internal Medicine I, Lahey Clinic Medical Center, Burlington, University Hospital Carl Gustav Carus Dresden (Author)
Josephine T Tauer - , University Hospital Carl Gustav Carus Dresden (Author)
Martin C Müller - , Heidelberg University (Author)
Andreas Hochhaus - , Jena University Hospital (Author)
Ingo Roeder - , Institute for Medical Informatics and Biometry, National Center for Tumor Diseases (NCT) Heidelberg (Author)
Ingmar Glauche - , Institute for Medical Informatics and Biometry (Author)

Adolescent, Antineoplastic Agents/therapeutic use, Child, Child, Preschool, Drug Administration Schedule, Female, Fusion Proteins, bcr-abl/antagonists & inhibitors, Gene Expression, Germany, Humans, Imatinib Mesylate/therapeutic use, Infant, Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy, Male, Protein Kinase Inhibitors/therapeutic use, RNA, Messenger/antagonists & inhibitors, Treatment Outcome